Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

Go back to Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

SmartPros Ltd. (SPRO) Tops Q3 EPS by 26c, Misses on Revenue

November 13, 2025 4:18 PM EST

SmartPros Ltd. (NASDAQ: SPRO) reported Q3 EPS of ($0.13), $0.26 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $12 million.

For earnings history and earnings-related data on SmartPros Ltd. (SPRO) click here.

... More